Cindy B. Matsen
( out of 179 reviews )

Cindy B. Matsen, MD, MSCI

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital North

2K, Gynecology and Mammography
Salt Lake City
801-213-4269
Directions

Sugar House Health Center

Salt Lake City
801-581-2000
Directions

  • Cindy B. Matsen is a fellowship trained breast surgeon at the University of Utah, Huntsman Cancer Institute. She is board certified in General Surgery and is an Associate Professor in the Department of Surgery and specializes in the surgical treatment of breast cancer and benign breast diseases. She received her undergraduate degree from the University of Oregon and her MD from the University of Chicago Pritzker School of Medicine. She then completed a residency in General Surgery at the University of Utah and a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York City. She has special interests in young breast cancer patients, doctor-patient communication, patient education, and decision making. She has research interests in shared decision making, health communication, and cancer care delivery. Her works focuses on better understanding how shared decision making is viewed and implemented by providers and designing interventions to improve the shared decision making process. She is particularly interested in preference elicitation and how better training of providers in preference elicitation techniques can improve cancer outcomes. She enjoys collaborative work and has ongoing collaborations with researchers in communication, population health, epidemiology, engineering, and molecular biology. Her overall goal is to improve our ability to provide patient-centered care for cancer patients.

    Specialties

    Board Certification

    American Board of Surgery (Sub: General Surgery)

    Patient Rating

    5.0 /5
    ( out of 179 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    February 16, 2025
    HUNTSMAN CANCER CENTER

    Such a kind and caring person who really took the time to educate me and listen to my concerns

    February 02, 2025
    HUNTSMAN CANCER CENTER

    The best surgeon I have ever had. Post opp pain was minimal, and I have minimal scaring. I couldn't have asked for better results. Plus she is so upbeat and positive. She really sets you at ease. I think she is a wonderful doctor.

    February 02, 2025
    SUGAR HOUSE HEALTH CENTER

    Dr Matsen is kind and compassionate, while also being very knowledgeable and thorough. I highly recommend her.

    January 18, 2025
    SUGAR HOUSE HEALTH CENTER

    I had a lumpectomy done through another provider and had a lot of problems with aftercare and getting the information that I needed to move forward. I switched my care to Dr. Matsen's office and she was great at explaining what my cancer entailed and providing me with information I could take home, and then setting up an action plan to move forward. I had a re-excision lumpectomy and I couldn't be more pleased. Even though I have now had two substantial lumpectomies, Dr. Matsen took care with the look of my breast. I feel like my breast now looks better than it did after the original lumpectomy. Quite the feat! She is a wonderful provider, and I would happily recommend her to friends and family in need of care.

    January 18, 2025
    HUNTSMAN CANCER CENTER

    I LOVE Dr. Matsen!!! She is so personable and treats me with total respect and explains everything so well. I trust her implicitly.

    December 21, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Matsen is the best! [TRANSLATED]

    November 22, 2024
    SUGAR HOUSE HEALTH CENTER

    It has been a privilege to be treated by Dr Matsen during the past 5 years. She has been a lifeline as I battled breast cancer, and her care was greatly instrumental in my recovery from this terrible disease. If I had to go through this ordeal, I am forever grateful that Dr. Matsen has been by my side.

    November 09, 2024
    HUNTSMAN CANCER CENTER

    Dr Matsen is very caring and personable. She takes time to explain things and then listens. She made me feel very comfortable from the beginning. Her kindness and compassion were so much appreciated.

    November 08, 2024
    SUGAR HOUSE HEALTH CENTER

    Compassionate, caring, knowledgeable and willing to listen and answer questions. Helped make a very stressful diagnosis understandable.

  • Cindy B. Matsen is a fellowship trained breast surgeon at the University of Utah, Huntsman Cancer Institute. She is board certified in General Surgery and is an Associate Professor in the Department of Surgery and specializes in the surgical treatment of breast cancer and benign breast diseases. She received her undergraduate degree from the University of Oregon and her MD from the University of Chicago Pritzker School of Medicine. She then completed a residency in General Surgery at the University of Utah and a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York City. She has special interests in young breast cancer patients, doctor-patient communication, patient education, and decision making. She has research interests in shared decision making, health communication, and cancer care delivery. Her works focuses on better understanding how shared decision making is viewed and implemented by providers and designing interventions to improve the shared decision making process. She is particularly interested in preference elicitation and how better training of providers in preference elicitation techniques can improve cancer outcomes. She enjoys collaborative work and has ongoing collaborations with researchers in communication, population health, epidemiology, engineering, and molecular biology. Her overall goal is to improve our ability to provide patient-centered care for cancer patients.

    Board Certification and Academic Information

    Academic Departments Surgery -Associate Professor
    Academic Divisions Surgical Oncology
    Board Certification
    American Board of Surgery (Sub: General Surgery)

    Education history

    Graduate Training Health Services Research - University of Utah M.S.C.I
    Fellowship Breast Surgical Oncology - Memorial Sloan-Kettering Cancer Center Fellow
    Residency General Surgery - University of Utah Affiliated Hospitals Resident
    Professional Medical Medicine - University of Chicago Pritzker School of Medicine M.D.
    Undergraduate Biology - University of Oregon B.S.

    Selected Publications

    Journal Article

    1. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle T, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA (2024). ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. (Read full article)
    2. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA (2024). Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. (Read full article)
    3. Vaklavas C, Matsen CB, Chu Z, Boucher KM, Scherer SD, Pathi S, Beck A, Brownson KE, Buys SS, Chittoria N, DAstous E, Gulbahce HE, Henry NL, Kimani S, Porretta J, Rosenthal R, Ward J, Wei M, Welm BE, Welm AL (2024). TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer. JCO Precis Oncol, 8, e2300724. (Read full article)
    4. Amann ES, Ose J, Hathaway CA, Oswald LB, Hardikar S, Himbert C, Chellam V, Lin T, Daniels B, Kirchhoff AC, Gigic B, Grossman D, Tward J, Varghese TK Jr, Shibata D, Figueiredo JC, Toriola AT, Beck A, Scaife C, Barnes CA, Matsen C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Grady WM, Schneider M, Dinkel A, Islam JY, Gonzalez BD, Otto AK, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2024). Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic. J Behav Med, 47(3), 405-421. (Read full article)
    5. King AJ, Dunbar NM, Margolin D, Chunara R, Tong C, Jih-Vieira L, Matsen CB, Niederdeppe J (2023). Global prevalence and content of information about alcohol use as a cancer risk factor on Twitter. Prev Med, 177, 107728. (Read full article)
    6. Covington MF, Hoffman JM, Morton KA, Buckway B, Boucher KM, Rosenthal R, Porretta J, Brownson KE, Matsen CB, Vaklavas C, Ward JH, Wei M, Buys SS, Chittoria N, Yakish ED, Archibald ZG, Burrell LD, Butterfield RI, Yap JT (2023). Prospective Pilot Study of (18)F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas. AJR Am J Roentgenol, 221(2), 228-239. (Read full article)
    7. Erickson JR, Pahlkotter MK, Thielking PD, Porretta JM, Rosenthal R, Matsen CB, Brownson KE (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center’s perspective. Patient Exp J, 10(2), 133-137. (Read full article)
    8. Morris BB, Smith JP, Zhang Q, Jiang Z, Hampton OA, Churchman ML, Arnold SM, Owen DH, Gray JE, Dillon PM, Soliman HH, Stover DG, Colman H, Chakravarti A, Shain KH, Silva AS, Villano JL, Vogelbaum MA, Borges VF, Akerley WL, Gentzler RD, Hall RD, Matsen CB, Ulrich CM, Post AR, Nix DA, Singer EA, Larner JM, Stukenberg PT, Jones DR, Mayo MW (2022). Replicative Instability Drives Cancer Progression. Biomolecules, 12(11). (Read full article)
    9. Teller P, Nguyen TT, Tseng J, Allen L, Matsen CB, Bellavance E, Kaufman D, Hieken T, Nagel S, Patten C, Pomerenke L, Tevis SE, Sarantou T (2022). Innovation in Breast Surgery: Practical and Ethical Considerations. Ann Surg Oncol, 29(10), 6144-6150. (Read full article)
    10. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2022). Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Cancer Causes Control, 33(7), 939-950. (Read full article)
    11. Goodwin IA, Luo J, Magno-Pardon DA, Veith J, Willcockson J, Carter G, Matsen C, Kwok AC, Agarwal CA (2022). Current Practices in the Pathologic Assessment of Breast Tissue in Transmasculine Chest Surgery. Plast Reconstr Surg, 150(3), 516e-525e. (Read full article)
    12. Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK Jr, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM (2022). Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. J Rural Health, 38(4), 886-899. (Read full article)
    13. Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm AL (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer, 3(2), 232-250. (Read full article)
    14. Jimenez RB, Johnson AE, Horick NK, Hlubocky FJ, Lei Y, Matsen CB, Mayer EL, Collyar DE, LeBlanc TW, Donelan K, Mello MM, Peppercorn JM (2021). Do you mind if I record?: Perceptions and practice regarding patient requests to record clinic visits in oncology. Cancer, 128(2), 275-283. (Read full article)
    15. Walker HR, Evans E, Nirula R, Hyngstrom J, Matsen C, Nelson E, Pickron B, Zurbuchen E, Morrow EH (2021). "I need to have a fulfilling job": A qualitative study of surgeon well-being and professional fulfillment. Am J Surg, 223(1), 6-11. (Read full article)
    16. Serpico VJ, Mone MC, Zhang C, Presson AP, Killian H, Agarwal J, Matsen CB, Porretta J, Nelson EW, Junkins S (2021). Preoperative multimodal protocol reduced postoperative nausea and vomiting in patients undergoing mastectomy with reconstruction. J Plast Reconstr Aesthet Surg, 75(2), 528-535. (Read full article)
    17. Agarwal S, Pappas L, Matsen CB, Agarwal JP (2020). Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy. Cancer Med, 9(21), 8043-8052. (Read full article)
    18. Gutnik L, Allen CM, Presson AP, Matsen CB (2020). Breast Cancer Surgery Decision Role Perceptions and Choice of Surgery. Ann Surg Oncol, 27(10), 3623-3632. (Read full article)
    19. Serpico V, Mone M, Zhang C, Presson A, Matsen C, Junkins S, Killian H, Porretta J, Agarwal J, Nelson E (2020). Standard preoperative use of nonopioid multi-modal medications for patients undergoing mastectomy with immediate reconstruction and the effect on postoperative opioid needs. Breast J, 26(5), 966-970. (Read full article)
    20. Matsen CB, Ray D, Kaphingst KA, Zhang C, Presson AP, Finlayson SRG (2019). Patient Satisfaction With Decision Making Does Not Correlate With Patient Centeredness of Surgeons. J Surg Res, 246, 411-418. (Read full article)
    21. Taylor MA, Allen CM, Presson AP, Millar MM, Zurbuchen R, Matsen CB (2019). Exploring Surgeon Variability in Recommendations for Contralateral Prophylactic Mastectomy: What Matters Most? Ann Surg Oncol, 26(10), 3224-3231. (Read full article)
    22. Albright FS, Kohlmann W, Neumayer L, Buys SS, Matsen CB, Kaphingst KA, Cannon-Albright LA (2019). Population-based relative risks for specific family history constellations of breast cancer. Cancer Causes Control, 30(6), 581-590. (Read full article)
    23. Garlick JW, Olson KA, Downs-Kelly E, Bucher BT, Matsen CB (2018). Secretory breast carcinoma in an 8-year-old girl: A case report and literature review. Breast J, 24(6), 1055-1061. (Read full article)
    24. Kaphingst KA, Ivanovich J, Lyons S, Biesecker B, Dresser R, Elrick A, Matsen C, Goodman M (2018). Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors. Transl Behav Med, 8(1), 71-79. (Read full article)
    25. Frandsen JE, Cannon G, Kokeny KE, Gaffney DK, Matsen C, Wright M, Poppe MM (2017). Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review. Breast J, 24(1), 7-11. (Read full article)
    26. Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna S (2017). Breast cancer screening of pregnant and breastfeeding women with BRCA mutations. Breast Cancer Res Treat, 162(2), 225-230. (Read full article)
    27. Cohen AL, Factor RE, Mooney K, Salama ME, Wade M, Serpico V, Ostrander E, Nelson E, Porretta J, Matsen C, Bernard P, Boucher K, Neumayer L (2017). POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen. Breast, 31, 219-223. (Read full article)
    28. Kaphingst KA, Ivanovich J, Elrick A, Dresser R, Matsen C, Goodman MS (2016). How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age. Mol Genet Genomic Med, 4(6), 684-695. (Read full article)
    29. Matsen C, Villegas K, Eaton A, Stempel M, Manning A, Cody HS, Morrow M, Heerdt A (2016). Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon. Ann Surg Oncol, 23(8), 2456-61. (Read full article)
    30. Ugras S, Matsen C, Eaton A, Stempel M, Morrow M, Cody HS 3rd (2016). Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile? Ann Surg Oncol, 23(3), 744-8. (Read full article)
    31. Matsen CB, Mehrara B, Eaton A, Capko D, Berg A, Stempel M, Van Zee KJ, Pusic A, King TA, Cody HS 3rd, Pilewskie M, Cordeiro P, Sclafani L, Plitas G, Gemignani ML, Disa J, El-Tamer M, Morrow M (2016). Skin Flap Necrosis After Mastectomy With Reconstruction: A Prospective Study. Ann Surg Oncol, 23(1), 257-64. (Read full article)
    32. Frandsen J, Ly D, Cannon G, Suneja G, Matsen C, Gaffney DK, Wright M, Kokeny KE, Poppe MM (2015). In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. Int J Radiat Oncol Biol Phys, 93(5), 1096-103.
    33. Bowen M, Matsen C (2015). Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 trial (CALGB 150007/150012; ACRIN 6657): Cureton EL, Yau C, Alvarado MD, et al (Univ of California San Francisco; Et al) Ann Surg Oncol 21:2889-2896, 2014. J Med Device, 26(1), 63-65. (Read full article)
    34. Matsen CB (2015). Regional lymphatic recurrence after salvage surgery for ipsilateral breast tumor recurrence of breast cancer without local treatment for regional lymphatic basin: Ishitobi M, Matsushita A, Nakayama T, et al (Osaka Med Ctr for Cancer and Cardiovascular Diseases, Japan) J Surg Oncol 110:265-269, 2014. J Med Device, 26(2), 147-149. (Read full article)
    35. Poruk KE, Ying J, Chidester JR, Olson JR, Matsen CB, Neumayer L, Agarwal J (2015). Breast cancer recurrence after nipple-sparing mastectomy: one institution's experience. Am J Surg, 209(1), 212-7. (Read full article)
    36. Matsen CB, Hirsch A, Eaton A, Stempel M, Heerdt A, Van Zee KJ, Cody HS 3rd, Morrow M, Plitas G (2014). Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases. Ann Surg Oncol, 21(10), 3330-5. (Read full article)
    37. Gligorich KM, Vaden RM, Shelton DN, Wang G, Matsen CB, Looper RE, Sigman MS, Welm BE (2013). Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cells. Breast Cancer Res, 15(4), R58. (Read full article)
    38. Lum DH, Matsen C, Welm AL, Welm BE (2012). Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research. Curr Protoc Pharmacol, Chapter 14, Unit 14.22. (Read full article)
    39. Matsen CB, Luther SL, Stewart AK, Henderson WG, Kim H, Neumayer LA (2012). A match made in heaven? Trying to combine ACS-NSQIP and NCDB databases. J Surg Res, 175(1), 6-11. (Read full article)
    40. DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, Factor R, Matsen C, Milash BA, Nelson E, Neumayer L, Randall RL, Stijleman IJ, Welm BE, Welm AL (2011). Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med, 17(11), 1514-20. (Read full article)

    Review

    1. Singh P, Agnese D, Amin M, Barrio AV, Botty Van den Bruele A, Burke E, Danforth DN, Dirbas FM, Eladoumikdachi F, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Laronga C, Boughey J (2024). Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks. [Review]. Ann Surg Oncol, 31(4), 2212-2223. (Read full article)
    2. Matsen C, Van Zee KJ (03/2014). Use of Established Nomograms to Predict Non-Sentinel Lymph Node Metastasis. [Review]. Curr Breast Cancer Rep, 6(1).
    3. Matsen CB, Neumayer LA (2013). Breast cancer: a review for the general surgeon. [Review]. JAMA Surg, 148(10), 971-9. (Read full article)

    Book Chapter

    1. Matsen C, Neumayer L (2012). Hernia. In Matsen C|Neumayer L (Ed.), J Med Device (pp. 919-924). (Read full article)

    Commentary

    1. Matsen CB, Neumayer LA (2016). Commentary on Pilewskie M, Jochelson M, Gooch J et al. “Is Preoperative Axillary Imaging beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Dissection?” J Am Coll Surg. 2016 Feb;222(2):138-45.
    2. Matsen CB (2016). Commentary on Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy: Swisher SK, Vila J, Tucker SL, et al (The Univ of Texas MD Anderson Cancer Ctr, Houston) Ann Surg Oncol 23:749-756, 2016. 27(4), 306-307.
    3. Weitz A, Matsen CB (2016). Commentary on Differences in Response and Surgical management with neoadjuvant chemotherapy in invasive lobular vs ductal breast cancer. Truin W, Vugts G,, Roumen RM, et al. Ann Surg Oncol. 2016 Jan;23(1):51-7. 27(3), 222-224.
    4. Matsen CB (2016). Commentary on Regional Lymphatic Recurrence After Salvage Surgery for Ipsilateral Breast Tumor Recurrence of Breast Cancer Without Local Treatment for Regional Lymphatic Basin. 26(2).
    5. Bowen M and Matsen CB (April-June 2015). Commentary on Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012;ACRIN 6657). 26(1), 63-65.

    Case Report

    1. Maglic D, Moss W, Pires G, Agarwal A, Matsen C, Kwok A (2021). A Case Report of Misdiagnosed Breast Implant-associated Anaplastic Large Cell Lymphoma with Lymphatic Extension. Plast Reconstr Surg Glob Open, 9(11), e3916. (Read full article)

    Other

    1. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2021). Impact of the COVID-19 pandemic on exercise habits among cancer patients. United States. (Read full article)

    Video/Film/CD/Web/Podcast

    1. Matsen (January 2023). Got your regular mammogram? Here's when you might want an extra checkup - Studio 5 - KSL.com, January 5, 2023   https://studio5.ksl.com/got-regular-mammogram-extra-checkup/   [Video].
    2. Cindy B Matsen (2015). Introduction to the Huntsman Cancer Institute's Breast Cancer Clinic [Video]. Available: https://www.youtube.com/watch?v=3ZAMUx5wDSg.
    3. Cindy B Matsen (2015). What to Expect After Surgery [Video]. Available: https://www.youtube.com/watch?v=0YGH0MnN644.
    4. Cindy B Matsen (2015). Surgery for Breast Cancer [Video]. Available: https://www.youtube.com/watch?v=ZKtCgNBcY5c.
    5. Cindy B Matsen (2015). What We Need to Know to Treat Your Breast Cancer [Video]. Available: https://www.youtube.com/watch?v=0w1P8WLiWnY.

    Patent

    1. Matsen CB (2012). Zebularine as an Inhibitor of DNA Methylation. U.S. Patent No. 8207142B2. Washington, D.C.:U.S. Patent and Trademark Office.

  • News & Podcasts

    Huntsman Cancer Institute News

    Podcasts